A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- John Welch, MD, PhD
A2 Biotherapeutics
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Banner Health
Gilbert, Arizona, United States
Matthew Ulrickson, MDRecruiting - Ucsd Moores Cancer Center
La Jolla, California, United States
Sandip Patel, MDRecruiting - Ucla Medical Center
Los Angeles, California, United States
J. Randolph Hecht, MDRecruiting - Stanford University
Stanford, California, United States
Oliver Dorigo, MDRecruiting - Mayo Clinic
Jacksonville, Florida, United States
Yanyan Lou, MDRecruiting - Moffitt Cancer Center
Tampa, Florida, United States
Monica Avila, MDRecruiting - Mayo Clinic Rochester
Rochester, Minnesota, United States
Julian Molina, MD, PhDRecruiting - Washington University
St Louis, Missouri, United States
Jeffery Ward, MDRecruiting - Nyu Langone Medical Center
New York, New York, United States
Salman Punekar, MDRecruiting - the Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
Jinesh Gheeya, MD, PhDRecruiting - Vanderbilt University Medical Center
Nashville, Tennessee, United States
Cathy Eng, M.D., FACP, FASCORecruiting - Fred Hutchinson Cancer Center
Seattle, Washington, United States
David Zhen, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 Apr 2024
- Primary completion
- 30 Jun 2028
- Completion
- 30 Jun 2029
- Last update posted
- 12 Jun 2026
- Registered enrollment
- 474
- Registry id
- NCT06051695
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.